SuperCrowd
New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
LexaGene Life Sciences CF Investors, Inc.
N/A · DE · Filed Oct 31, 2023
LexaGene Life Sciences CF Investors, Inc. filed a Form C — new offering — with the SEC on Oct 31, 2023. The Regulation Crowdfunding offering seeks $25,750, up to a maximum of $5,000,000 on Dealmaker. Investors receive: Common Stock at $1.03. The offering closes 10-31-2024.
| Target raise | $25,750 |
|---|---|
| Maximum raise | $5,000,000 |
| Security | Common Stock @ $1.03 |
| Closes | 10-31-2024 |
| Portal | Dealmaker |
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.